Oaktree Specialty Lending Corporation (OCSL) Stock
Key stats
- Market cap
- $1.09B
- Price / Earnings ratio
- 26.1x
- EPS (TTM)
- $0.48
- Volume
- Loading
- 52-week high
- $13.91
- 52-week low
- $10.63
- Dividend yield
- 11.83%
- Dividend amount (latest)
- $0.34
Source: third-party data provider, as of November 13, 2026
Compare with OCSL
Recent news

Oaktree Specialty Lending Corporation Schedules Fourth Fiscal Quarter and Full Year 2026 Earnings Conference Call for November 17, 2026
Oaktree Specialty Lending Corporation Schedules Fourth Fiscal Quarter and Full Year 2026 Earnings Conference Call for November 17, 2026
OCSL

Oaktree Specialty Lending Corporation Prices Public Offering of $300,000,000 7.000% Notes due 2031
Oaktree Specialty Lending Corporation Prices Public Offering of $300,000,000 7.000% Notes due 2031
OCSL

Oaktree Specialty Lending Q3 Earnings Call Highlights
Oaktree Specialty Lending Q3 Earnings Call Highlights
OCSL

Oaktree Specialty Lending (OCSL) Q3 Earnings Surpass Estimates
Oaktree Specialty Lending (OCSL) Q3 Earnings Surpass Estimates
OCSL
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 59.34
- MACD 12/26/9
- 0.16
- EMA 9 of MACD
- 0.07
- MACD histogram
- 0.09
- SMA 50
- $12.12
- Price above SMA 50
- EMA 50
- $12.12
- Price above EMA 50
- SMA 200
- $12.07
- Price above SMA 200
- EMA 200
- $12.24
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 1 analyst rating
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $0.38 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Oaktree Specialty Lending Corporation Schedules Fourth Fiscal Quarter and Full Year 2026 Earnings Conference Call for November 17, 2026
Oaktree Specialty Lending Corporation Schedules Fourth Fiscal Quarter and Full Year 2026 Earnings Conference Call for November 17, 2026
OCSL

Oaktree Specialty Lending Corporation Prices Public Offering of $300,000,000 7.000% Notes due 2031
Oaktree Specialty Lending Corporation Prices Public Offering of $300,000,000 7.000% Notes due 2031
OCSL

Oaktree Specialty Lending Q3 Earnings Call Highlights
Oaktree Specialty Lending Q3 Earnings Call Highlights
OCSL

Oaktree Specialty Lending (OCSL) Q3 Earnings Surpass Estimates
Oaktree Specialty Lending (OCSL) Q3 Earnings Surpass Estimates
OCSL

Oaktree Specialty Lending Corporation Announces Third Fiscal Quarter 2026 Financial Results
Oaktree Specialty Lending Corporation Announces Third Fiscal Quarter 2026 Financial Results
OCSL

Oaktree Specialty Lending Corporation Schedules Third Fiscal Quarter Earnings Conference Call for August 5, 2026
Oaktree Specialty Lending Corporation Schedules Third Fiscal Quarter Earnings Conference Call for August 5, 2026
OCSL

Private credit dividends look less secure as cash coverage thins
Private credit dividends look less secure as cash coverage thins
OCSL

Oaktree Specialty Lending (OCSL) Tops Q2 Earnings Estimates
Oaktree Specialty Lending (OCSL) Tops Q2 Earnings Estimates
OCSL

Oaktree Specialty Lending Corporation Announces Second Fiscal Quarter 2026 Financial Results
Oaktree Specialty Lending Corporation Announces Second Fiscal Quarter 2026 Financial Results
OCSL

Oaktree Specialty Lending Corporation Schedules Second Fiscal Quarter Earnings Conference Call for May 5, 2026
Oaktree Specialty Lending Corporation Schedules Second Fiscal Quarter Earnings Conference Call for May 5, 2026
OCSL
News tone: automated (AI) classification of the article's content, not a price prediction.
About Oaktree Specialty Lending Corporation
Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The company operates as a single reportable segment and derives revenues from investing in originated loans and other securities, including broadly syndicated loans, of U.S. private companies and manages the business on a consolidated basis.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Armen Panossian J.D. | CEO & Co-Chief Investment Officer | 1976 |
| Mr. Christopher McKown | CFO & Treasurer | 1982 |
| Mr. Brett McKeone | Chief Operating Officer | — |
| Mr. Mathew M. Pendo | President | 1964 |
| Dr. Aman Kumar M.D. | Managing Director & Co-Portfolio Manager of Life Sciences Direct Lending | 1980 |
| Mr. Raghav Khanna | Co-Chief Investment Officer | 1984 |
| Mr. Dane Kleven | Senior VP & Head of Investor Relations | — |
| Ms. Mary Gallegly J.D. | MD,General Counsel & Secretary | — |
| Ms. Ashley Pak | Chief Compliance Officer | 1978 |
| Mr. Sandeep Kumar Khorana | Managing Director of Origination | 1973 |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 59.34
- MACD 12/26/9
- 0.16
- EMA 9 of MACD
- 0.07
- MACD histogram
- 0.09
- SMA 50
- $12.12
- Price above SMA 50
- EMA 50
- $12.12
- Price above EMA 50
- SMA 200
- $12.07
- Price above SMA 200
- EMA 200
- $12.24
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
1 analyst rating
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- -
- Average
- -
- High
- -
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -0.9 | +2.2 | ||||||||||
| 2022 | +0.0 | -1.7 | -1.2 | -4.3 | -1.4 | -7.0 | +5.1 | -2.7 | -11.8 | +8.9 | +7.8 | -4.5 |
| 2023 | -4.4 | -0.3 | -7.2 | -0.1 | -0.3 | +3.7 | +4.4 | -2.1 | -0.3 | -2.9 | +4.1 | +2.1 |
| 2024 | +3.8 | +2.2 | -0.1 | -0.8 | +0.1 | -4.4 | -3.5 | -1.0 | -4.3 | -0.4 | +2.4 | -7.2 |
| 2025 | +4.5 | +1.1 | -3.7 | -6.6 | +10.2 | -5.2 | +0.6 | +3.2 | -6.1 | +7.5 | -0.3 | -7.3 |
| 2026 | -3.1 | -7.4 | -1.4 | +12.8 | -7.0 | -1.1 | -4.4 | +11.1 | -9.2 | +1.3 | +0.2 |
Corporate actions
Upcoming
No upcoming corporate actions for OCSL




